SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-022192
Filing Date
2023-05-15
Accepted
2023-05-15 16:06:57
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgta-20230331.htm   iXBRL 10-Q 1642655
2 EX-31.1 mgta-ex31_1.htm EX-31.1 15918
3 EX-32.1 mgta-ex32_1.htm EX-32.1 12069
  Complete submission text file 0000950170-23-022192.txt   6227527

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgta-20230331_cal.xml EX-101.CAL 32118
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgta-20230331_def.xml EX-101.DEF 279195
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgta-20230331_lab.xml EX-101.LAB 368603
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgta-20230331_pre.xml EX-101.PRE 315112
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgta-20230331.xsd EX-101.SCH 44147
54 EXTRACTED XBRL INSTANCE DOCUMENT mgta-20230331_htm.xml XML 995551
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 23922130
SIC: 2834 Pharmaceutical Preparations